[1]李灵玉王聪陈忠兰蒋艳邹树芳.国外普适性卫生技术评估工具分析及对我国的启示[J].中国卫生质量管理,2023,30(04):076-81.[doi:10.13912/j.cnki.chqm.2023.30.4.19 ]
　LI Lingyu,WANG Cong,CHEN Zhonglan.Foreign Universal Health Technology Assessment Tools and the Inspiration for China[J].Chinese Health Quality Management,2023,30(04):076-81.[doi:10.13912/j.cnki.chqm.2023.30.4.19 ]
点击复制

国外普适性卫生技术评估工具分析及对我国的启示
分享到：

《中国卫生质量管理》[ISSN:1006-7515/CN:CN 61-1283/R]

卷:
第30卷
期数:
2023年04期
页码:
076-81
栏目:
卫生技术评估专栏
出版日期:
2023-04-15

文章信息/Info

Title:
Foreign Universal Health Technology Assessment Tools and the Inspiration for China
作者:
李灵玉王聪陈忠兰蒋艳邹树芳
西南医科大学护理学院
Author(s):
LI Lingyu; WANG Cong; CHEN Zhonglan
Nursing School, Southwest Medical University
关键词:
卫生技术评估; 评估工具; 普适性
Keywords:
Health Technology Assessment;  Assessment Tools;  Universality
分类号:
R197.323
DOI:
10.13912/j.cnki.chqm.2023.30.4.19
文献标志码:
A
摘要:
目的介绍国外典型普适性卫生技术评估（HTA）工具，为我国HTA工具的开发提供参考。方法检索文献数据库及HTA相关网站，筛选关于欧洲、加拿大、美国普适性HTA工具的文献。结果共纳入19篇文献，涉及6个HTA工具，包括HTA核心模型、Mini-HTA模版、多准则决策分析高级价值框架、循证决策支持程序、证据与价值对决策的影响框架、医疗技术综合评估框架。结论为促进我国HTA标准化与规范化，建议明确HTA标准，开发本土HTA工具，注重HTA工具灵活性，搭建HTA互联网平台并加强多方参与。
Abstract:
ObjectiveTo introduce typical foreign universal Health Technology Assessment (HTA) tools and provide reference for the development of HTA tools in China.MethodsLiterature databases and HTA-related websites were searched to screen studies related to universal HTA tools in Europe, Canada, and the United States.ResultsA total of 19 literatures were included, involving 6 HTA tools, including HTA core model, Mini-HTA template, advanced value framework for multi-criteria decision analysis, evidence-based decision support procedures, framework for the influence of evidence and value on decision making, and framework for comprehensive evaluation of medical technology.Conclusion In order to promote the standardization and normalization of HTA in China, it is suggested to clarify HTA standard, develop local HTA tools, pay attention to the flexibility of HTA tools, build HTA online platforms, and strengthen multi-stakeholder participation.

参考文献/References:

［1］O'ROURKE B, OORTWIJN W, SCHULLER T. The new definition of health technology assessment: a milestone in international collaboration［J］. Int J Technol Assess Health Care, 2020, 36(3): 187-190. ［2］CHEN YY, HE Y, CHI XYZ, et al. Development of health technology assessment in China: new challenges［J］. Biosci Trends, 2018, 12(2): 102-108. ［3］GHAZINOORY S, MAJIDI B, NASRI S, et al. Differences between health technology assessment topics in high- and middle-income countries: a scoping review［J］. Arch Public Health, 2021, 79(1): 225. ［4］WANG HY, JIN CL, BAI F, et al. Driving factors and mode transformation regarding health technology assessment (HTA) in China: problems and recommendations［J］. Biosci Trends, 2019, 13(2): 110-116. ［5］吴 雪, 徐思敏, 戴泽琦, 等. 国内外卫生技术评估机构的概况性综述［J］. 中国实验方剂学杂志, 2022, 28(20): 178-185. ［6］European Network for Health Technology Assessment. HTA Core Model for the production of core HTAs (version 3.0)［EB/OL］. (2016-01-25) ［2022-06-26］.https://www.eunethta.eu/hta-core-model/. ［7］KRISTENSEN FB, LAMPE K, WILD C, et al. The HTA Core Model()-10 years of developing an international framework to share multidimensional value assessment［J］. Value Health, 2017, 20(2): 244-250. ［8］LAMPE K, MKELM, GARRIDO MV, et al. The HTA core model: a novel method for producing and reporting health technology assessments［J］. Int J Technol Assess Health Care, 2009, 25(Suppl 2): 9-20. ［9］李艳博, 陈校云, 余中光, 等. 欧洲卫生技术评估网络的核心评估模型及应用［J］. 中国卫生信息管理杂志, 2016, 13(4): 370-375. ［10］欧洲卫生技术评估网络. 卫生技术评估核心模型：使用指南及开发程序［M］.王海银，何江江, 译. 上海: 上海交通大学出版社, 2018: 1-2. ［11］Adopting Hospital Based Health Technology Assessment. The AdHopHTA Toolkit［EB/OL］. (2015-11-23) ［2022-06-26］.http://www.adhophta.eu/adhophta-toolkit. ［12］Adopting Hospital based Health Technology Assessment. AdHopHTA mini-HTA template［EB/OL］. (2015-05-26) ［2022-06-26］.http://www.adhophta.eu/toolkit/guiding.html?tools=1. ［13］欧盟AdHopHTA项目组. 医院卫生技术评估：手册与工具包［M］.何江江，王海银, 译. 上海: 上海交通大学出版社, 2017: 5-6. ［14］Advancing and strengthening the methodological tools and practices relating to the application and implementation of Health Technology Assessment (HTA)［EB/OL］.(2016-07-13) ［2022-06-26］.https://cordis.europa.eu/project/id/305983/reporti ng. ［15］张 强, 王志飞, 谢雁鸣, 等. 国外普适性药物价值评价工具对构建中成药药物价值评价工具的思考［J］. 中国中药杂志, 2021, 46(8): 1973-1979. ［16］ANGELIS A, KANAVOS P. Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: the Advance Value Framework［J］. Soc Sci Med, 2017, 188: 137-156. ［17］ANGELIS A, LINCH M, MONTIBELLER G, et al. Multiple criteria decision analysis for HTA across four EU Member States: piloting the Advance Value Framework［J］. Soc Sci Med, 2020, 246: 112595. ［18］ANGELIS A, KANAVOS P. Value-based assessment of new medical technologies: towards a robust methodological framework for the application of multiple criteria decision analysis in the context of health technology assessment［J］. Pharmacoeconomics, 2016, 34(5): 435-446. ［19］POULIN P, AUSTEN L, KORTBEEK JB, et al. New technologies and surgical innovation: five years of a local health technology assessment program in a surgical department［J］. Surg Innov, 2012, 19(2): 187-199. ［20］POULIN P, AUSTEN L, SCOTT CM, et al. Multi-criteria development and incorporation into decision tools for health technology adoption［J］. J Health Organ Manag, 2013, 27(2): 246-265. ［21］张曙欣, 陈校云, 黄婉茹, 等. 加拿大循证决策支持程序及对我国的启示［J］. 中国卫生信息管理杂志, 2018, 15(2): 152-155. ［22］GOETGHEBEUR MM, WAGNER M, KHOURY H, et al. Evidence and value: impact on DEcisionMaking the EVIDEM framework and potential applications［J］. BMC Health Serv Res, 2008, 8: 270. ［23］GOETGHEBEUR MM, CELLIER MS. Can reflective multicriteria be the new paradigm for healthcare decision-making? The EVIDEM journey［J］. Cost Eff Resour Alloc, 2018, 16(Suppl 1): 54. ［24］戴泽琦, 徐思敏, 吴 雪, 等. EVIDEM框架介绍及其在卫生决策中的应用［J］. 中国实验方剂学杂志, 2022, 28(4): 212-218. ［25］Advanced Medical Technology Association. A framework for comprehensive assessment of medical technologies［EB/OL］. (2017-05-11) ［2022-06-26］.https://www.advamed.org/member-center/resource-library/a-framework-for-comprehensive-assessment-of-medical-technologies/. ［26］张金穗, 肖 月, 赵 琨, 等. 精准医学技术的国际价值判断框架指标构建及归纳［J］. 中国卫生经济, 2020, 39(1): 26-29. ［27］宋子扬, 尉耘翠, 聂晓璐, 等. 基于卫生技术评估联合多准则决策分析建立我国儿童用药临床综合评价方法［J］. 药物流行病学杂志, 2019, 28(10): 681-686. ［28］杜雨晗, 靳会欣, 薛朝军, 等. 基于EVIDEM医疗机构多准则循证决策框架评估伏诺拉生与艾普拉唑［J］. 中国医院药学杂志, 2022, 42(9): 940-944.［29］廖 星, 戴泽琦, 吴 雪, 等. 采用EVIDEM框架开展中成药临床综合评价［J］. 中国中药杂志, 2022, 47(10): 2833-2840. ［30］郭武栋, 李 雪, 陈金榆, 等. 药品多维度价值判断评估工具包模拟案例［J］. 中国卫生资源, 2020, 23(4): 348-351,372. ［31］唐 密, 杨 海. 我院新增医用耗材采购流程及入选标准探讨［J］. 中国医疗设备, 2018, 33(10): 162-165. ［32］唐 檬, 陈英耀, 茅艺伟,等. 中国卫生技术评估决策转化的动阻力分析［J］. 中国卫生质量管理, 2015, 22(3):81-83. ［33］王海银, 孙 辉, 王昊德,等. 价值重塑下的我国卫生技术评估发展与展望［J］. 中国卫生质量管理, 2022,28(6):1-3,8. ［34］符雨嫣, 王美凤, 罗雅双, 等. 英国、加拿大的卫生技术评估机构协作经验［J］. 中国卫生经济, 2022, 41(2): 93-96. ［35］陈英耀, 刘文彬, 耿劲松,等. 发展我国卫生技术评估的政策建议［J］. 中国卫生质量管理, 2015, 22(1):61-64. ［36］王海银, 张晓溪, 房 良, 等. 我国卫生技术评估流程规范研究［J］. 中国卫生质量管理, 2016, 23(6): 60-63. ［37］王 怡, 陈嘉珩, 胡秀静, 等. 不同国家卫生技术评估应用现状及对“健康中国”建设启示［J］. 中国公共卫生, 2021, 37(11): 1713-1717.

相似文献/References:

[1]唐檬,陈英耀,茅艺伟,等.中国卫生技术评估决策转化现状及影响因素的定性研究[J].中国卫生质量管理,2015,22(06):095.
[2]王海银 张晓溪 房良 金春林.我国卫生技术评估流程规范研究[J].中国卫生质量管理,2016,23(06):060.[doi:10.13912/j.cnki.chqm.2016.23.6.21]
[3]魏巍 张涛 鱼敏.便携式早期清创冲洗器的卫生技术评估[J].中国卫生质量管理,2018,25(03):079.[doi:10.13912/j.cnki.chqm.2018.25.3.24]
[4]张曙欣 陈校云 冯力 宋杨杨 胡可慧 黄婉茹 裴治纲.澳大利亚和新西兰新兴卫生技术水平扫描网络的实践与启示[J].中国卫生质量管理,2019,26(02):106.[doi:10.13912/j.cnki.chqm.2019.26.2.31]
[5]孙辉 金春林 程文迪 房良 王海银.西班牙卫生技术评估的发展应用及启示[J].中国卫生质量管理,2019,26(03):106.[doi:10.13912/j.cnki.chqm.2019.26.3.29]
[6]王海银 丛郦萱 彭颖 王美凤 金春林.我国新医疗技术的定价及支付优化策略探讨[J].中国卫生质量管理,2020,27(01):105.[doi:10.13912/j.cnki.chqm.2020.27.1.27]
[7]程文迪 孙辉 房良 王海银.泰国卫生技术评估机制建设现状及启示[J].中国卫生质量管理,2020,27(01):109.[doi:10.13912/j.cnki.chqm.2020.27.1.28]
[8]邱英鹏赵翔肖月赵羽西.高值医用耗材定义与治理内涵研究[J].中国卫生质量管理,2021,28(05):001.[doi:10.13912/j.cnki.chqm.2021.28.5.01 ]
　QIU Yingpeng,ZHAO Xiang,XIAO Yue.The Definition and Governance Connotation of High Value Medical Consumables[J].Chinese Health Quality Management,2021,28(04):001.[doi:10.13912/j.cnki.chqm.2021.28.5.01 ]
[9]赵羽西邱英鹏肖月.英国高值医用耗材准入及招采管理经验分享：以英格兰为例[J].中国卫生质量管理,2021,28(05):008.[doi:10.13912/j.cnki.chqm.2021.28.5.03 ]
　ZHAO Yuxi,QIU Yingpeng,XIAO Yue.Access and Procurement Management of High Value Medical Consumables in the UK: A Case Study of England[J].Chinese Health Quality Management,2021,28(04):008.[doi:10.13912/j.cnki.chqm.2021.28.5.03 ]
[10]邱英鹏赵羽西赵翔肖月.澳大利亚假体类高值医用耗材医保准入管理经验及启示[J].中国卫生质量管理,2021,28(05):012.[doi:10.13912/j.cnki.chqm.2021.28.5.04 ]
　QIU Yingpeng,ZHAO Yuxi,ZHAO Xiang.Experience in Medical Insurance Access Management of Prosthetic High Value Medical Consumables in Australia and Its Implications[J].Chinese Health Quality Management,2021,28(04):012.[doi:10.13912/j.cnki.chqm.2021.28.5.04 ]

更新日期/Last Update: 2023-04-15